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The influenza A hemagglutinin (HA)' plays a major role in initiation of infec-
tion and in the pathogenesis of influenzaA viruses (1). To escape detection from
immune surveillance mechanisms, the influenza HA evolves by continuously ac-
cumulating point mutations, i.e ., antigenic drift, orby sporadic recombination be-
tween distantly related influenza strains, which results in the expression of a sero-
logically distinct HA subtype, i.e ., antigenic shift (2, 3) . The influenza HA serves
as the major target for neutralizing antibodies, and the critical recognition sites for
these antibodies have been localized to four or five distinct regions on the three-
dimensional structure of theHA (4-6) . The influenzaHA is also a target antigen
for both class I and class II MHC-restricted T lymphocytes (7-12) . Class ICTL
directed to influenza virus antigens, including the HA, have been shown to play
an important role in recovery from viral infection (13-15) .
In contrast to antibody, the antigenreceptor on Tlymphocytes directed to foreign
antigens such as viral polypeptides does not recognize free antigen, but rather, for-
eign antigen in conjunction with products of the MHC (16) . It is now clear that
class II MHC-restrictedT lymphocytes predominantly recognize nonnative processed
forms of foreign antigens (17, 18) . Recent evidence likewise supports the view that
class IT lymphocytes also recognize nonnative forms of antigen on the cell surface
(19-21), although the processing and presentation events for the two classes of T
lymphocytes occur via different pathways (22) . For both class I and class IITlym-
phocytes theprocessing events can be bypassed by use of synthetic peptides (23-26) .
In ourprevious studies ofclass ICTL recognition of the influenzaÀ/JAP/57 HA,
we described several distinct patterns ofHA recognition, e.g ., strain specific and
crossreactive, among HA-specific H-2Kd-restricted CTL directed to A/JAP/57
influenza virus of the H2N2 subtype (27) . We have mapped these specificities to
two immunodominant sites on the A/JAP/57 HA, which can be mimicked by syn-
thetic peptides corresponding to residues 202-221 and 523-545 of theHA (28). In
this paper, we have explored the fine specificity ofapanel ofA/JAP/57 strain-specific
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class I CTL clones directed to the HA 202-221 site using virus strains with antigeni-
cally related HAs. We show that CTL of several different fine specificities map to
the HA region spanning residues 202-221. Furthermore, we show that the HA 202-221
immunodominant region can be subdivided into two distinct yet overlapping epi-
topes and that amino acid substitutions that have occurred via antibody-mediated
antigenic drift can also influence class I CTL recognition.
Materials and Methods
Mice.
￿
BALB/c Byj (H-2d) and CB6Fi/J (H-2d"b) mice were purchased from TheJackson
Laboratory, Bar Harbor, ME.
Viruses.
￿
Influenza H2N2 strains A/JAP/305/57, A/Shanghai/57, A/Singapore/57, A/RI/
5*/57, A/Guiyang/1/57, A/Zhang/4/57, A/AA/23/57, A/Okuda/57, A/England/1/61, and in-
fluenza strain B/LEE/40 were grown in the allantoic cavity of 10-d-old chicken embryos. In-
fectious allantoic fluid was harvested 2 d later and aliquots were stored at -70°C (29). A
panel ofmAb-selected variants ofA/JAP/305/57 and A/Guiyang/1/57 were generously provided
by R. Webster (St. Jude Children's Research Hospital, Memphis, TN) and grown as de-
scribed above (30).
Cell Lines.
￿
The P815 (H-2d) mastocytoma cell line was maintained in DME (Gibco
Laboratories, Grand Island, NY) and supplemented with 10% (vol/vol) FCS and 1% (wt/vol)
glutamine.
Sequencing of Viral RNA.
￿
The viral genome in the region of the 202-221 site of the HA
gene was sequenced by primer extension (31). Briefly, influenza virion RNA was isolated
by lysis ofthe virions with an 0.5% SDS extraction buffer, digestion with proteinase K (Sigma
Chemical Co., St. Louis, MO), and extraction with phenol/chloroform. A 15-mer oligonucle-
otide located 40-50 by upstream of the HA 202-221 region was used to prime the synthesis
of DNA complementary to virion RNA in the presence of dideoxynucleoside triphosphates
(32) using AMV reverse transcriptase (Life Sciences, Inc., St. Petersburg, FL).
Peptides.
￿
Synthetic peptides corresponding to residues 202-221 of the A/JAP/305/57,
A/Zhang/4/57, A/GV17, and A/AA/23/57 HA glycoproteins were produced on an automated
solid-phase peptide synthesizer from Applied Biosystems (Foster City, CA). All other nested
peptides were produced manually on a rapid amino multiple peptide synthesizer system
(DuPont Co., Wilmington, DE).
TCell Clones.
￿
The cloned T lymphocytes were derived from BALB/c or BALB/c x C57BL/6
(CB6F,) mice. The procedures developed to establish and maintain them as well as anal-
yses of their viral specificity have been described in detail (27, 33). Briefly, the clones were
passaged weekly in the presence of A/JAP/57-infected, irradiated splenocytes in Iscove's
modified Dubecco's medium (Gibco Laboratories), 10% (vol/vol) FCS, 1% glutamine, 5 x
10' M 2-ME, antibiotics, and supplementation with 10% (vol/vol) culture supernatant of
Con A-activated rat splenocytes as a source of IL-2 .
Assayfor Cell-mediated Cytotoxicity.
￿
P815 cells were used as targets in standard "Cr release
assays and the resultant data were analyzed as previously described (29). For assays in which
synthetic peptides were used, the peptides were diluted in assay medium to the appropriate
concentration and added to the clones and target cells in the 96-well assay plates.
Results
Fine Specificity ofHA-speck Class IMHC-restricted CTLfor H2N2 Field Strains.
￿
We
previously analyzed the fine specificity of H-2Kd-restricted CTL clones directed to
the A/JAP/57 (H2N2) HA and found that three distinct fine specificity patterns are
discernible among these clones (27). Least frequent (<10%) are crossreactive CTL
clones that recognize a conserved epitope present on HA ofboth the HIN1 and H2N2
subtypes. At a somewhat higher frequency (10-30%) are CTL clones that recognize
an epitope conserved among all HAs ofthe H2N2 subtype. Both the subtype-specificSWEETSER ET AL.
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and the crossreactive epitopes have been localized to a site within the transmem-
brane domain of the A/JAP/57 HA corresponding to residues 523-545 of the pri-
mary HA translation product (28).
The most frequent pattern (60-80%) is exhibited by CTL clones that recognize
theHA ofthe immunizing strain A/JAP/57 butnot theHA ofH2N2 strains isolated
laterduring the 1957-1968 intrapandemic period (27). In an attemptto better define
thefinespecificity ofthese "strain-specific" CTL clones and the HA epitope(s) recog-
nized, weexamined the reactivity ofthese clones with human influenza field isolates
whose HAare serologicallyhighly crossreactive with theA/JAP/57 HA (30). AsTable
I demonstrates, the HA of four field strains, A/Guiyang/57, A/RI/5+/57, A/Shang-
hai/57, and A/Singapore/57, are recognized by apanel ofKd-restricted HA-specific
CTL clones as efficiently as previously reported for the A/JAP/57 HA. The HAs
of two other strains, A/AA/57 and A/Zhang/57, were differentially recognized by
the clones. Clone 40-2 recognizes cells infected with A/Zhang/57 but fails to recog-
nize cells infected with A/AA/57. On the other hand, clones 11-1, 14-1, 14-2, 17-2,
and 17-4 efficiently recognize the A/AA/57 HA but not target cells expressing the
A/Zhang/57 HA. It should be noted that clones 17-2 and 17-4 did show a low level
ofreactivity onA/Zhang/57-infected targets(see Discussion). These results suggest
thatthere may betwo distinguishable epitopes on the A/JAP/57 HA and that these
epitopes are differentially present on the A/Zhang/57 and A/AA/57 HAs.
CTL Recognition ofan mAb-selected HA Variant.
￿
The field strains used in the above
analysis were isolated at approximately the same time as the prototype A/JAP/57
virus. TheirHAs showminorserological antigenic differences (30) that reflectspecific
amino aciddifferencesinthe HAs and arebelieved to occur underthe selectivepres-
sure of neutralizing antibody. Since the class I CTL clones could distinguish be-
tween HAswith relatively minor antibody-driven antigenic changes, we considered
TABLE I
Recognition of H2N2 Influenza Field Strains by
HA-specific Class I CTL Clones
P815 mastocytoma cells were labeled with S'Cr, in-
fected with the indicated influenza virus strain, and
used as targets in a standard 6-h S1Cr release assay
(see Materials and Methods).
1 Indicates virus strain used to infect target cell.
S Indicates class I CTL clone used to screen infected
target cells.
II Values are the mean percent specific release from
triplicate samples. SEs were <5% ofmean values and
are omitted. The E/T ratio is 5:1 .
Virus strainst
Percent Specific S1Cr release
from target cells'
40-25 11-1 14-1 14-2 17-2 17-4
Uninfected 811 4 11 3 2 4
A/Shanghai/1/57 88 65 62 39 53 84
A/Singapore/202/57 86 74 72 52 62 80
A/RI/5+/57 83 59 56 34 48 68
A/Guiyang/1/57 87 72 74 57 65 81
A/Zhang/4/57 84 6 15 3 11 26
A/AA/23/57 11 72 77 57 68 811360
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the possibility that the antigenic epitope(s) recognized by these CTL clones may
overlap with HA site(s) recognized by neutralizing anti-HA antibody. This notion
is further supported by the fact that the HA region recognized bythese class I CTL
clones (HA 202-221) (28) is located within the globular head of the HA near the
putative sialic acid binding site ofthe HA and several residues are exposed to the
external milieu (6).
To further explore the possibility of overlap between class I CTL and antibody
in HA recognition, we took a large panel oflaboratory variants of the A/JAP/57
and A/Guiyang/57 viruses that hadbeen selected for resistance toneutralizing mAbs
directed to the A/JAP/57 and A/Guiyang/57 HAs (30) and screened target cells in-
fected with these laboratory variants for recognition by the class I CTL clones. Of
the 19 distinct variants examined, 18 are recognized as efficiently as the parental
A/JAP/57 and A/Guiyang/57 HAs (not shown). One variant, A/GV17, selected with
anmAb against theA/Guiyang/57 virus (30), isdifferentially recognized bytheclones.
Table II shows the results of an analysis of the recognition of target cells infected
with the A/GV17 virus by several class I CTL clones. Clones 11-1, 14-1, 14-2, 17-2,
and 17-4, which do not recognize the A/Zhang/57 HA, also do not recognize the
A/GV17 HA. Clone40-2and another clonewith asimilarspecificity, 40-1, do recog-
nize the A/GV17 HA. These two clones (40-1, 40-2) also lyse target cells infected
withA/Zhang/57, but notA/AA/57 (Table I). The mAb usedto generate the A/GV17
variant was tested for its ability to block recognition ofA/Guiyang/57-infected cells
by the class I CTL clones in a standard "Cr release assay. No inhibition oflysis
oftarget cells infected with A/Guiyang/57 or A/GV17 by clones 11-1, 14-1, or 14-2
was observed (data not shown).
Single AminoAcid ChangesDefine Subsites within a CTL RecognitionSite.
￿
The evidence
in Table II suggested thatthe A/GV17 HAhad undergone an antibody-driven selec-
tion of a mutational event that resulted in altered recognition by a subset ofclass
TABLE II
Recognition of mAb-selected Variant AIGV17 by
HA-speck Class I CTL Clones
` As in Table I.
$ The HA-specific CTL clones listed were tested for cytolytic activity on target
cells infected with the indicated influenza strain. Data from two independent
experiments are shown.
5 Values are the mean percent specific lysis as noted in Table 1 . The E/T ratio
is 5:1 .
Exp.
CTL
clones$
Percent specific
A/JAP/57
5'Cr release from
A/Guiyang/57
infected target
A/GV17
cells`
B/Lee
1 11-1 505 40 9 1
14-1 56 48 10 4
14-2 35 23 2 2
40-1 67 58 42 13
40-2 57 40 40 6
2 11-1 47 72 11 7
17-2 33 65 5 2
17-4 51 81 11 4
40-2 70 87 83 7SWEETSER ET AL.
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I CTL clones. We therefore wanted to determine whether A/GV17 had undergone
a mutation within'the HA 202-221 site provisionally defined as the region ofthe
HA recognized by these Kd-restricted CTL clones. Also, since the alteration in the
A/GV17 HAresulted in aCTL recognition pattern similar to the A/Zhang/57 HA,
it was ofinterest to determine whether a comparable mutation had occurred in the
A/Zhang/57 HA. To determine the amino acid sequence ofthe site in A/Zhang/57
and A/GV17 homologous to the A/JAP/57 HA 202-221 site, we sequenced by
oligonucleotide-directed primer extension, theviral RNAofA/Zhang/57, A/GV17,
and A/Guiyang/57, along with several other 1957 isolates in the region of the HA
gene encompassing HA 202-221. Fig. 1 shows the derived amino acid sequence of
these HAs in the region corresponding to the A/JAP/57 HA 202-221. The HAs of
A/Guiyang/57, A/Shanghai/57, and A/Singapore/57 strains that are recognized by
the CTL clones are identical in sequence to the A/JAP/57 HA in the 202-221 site.
On the otherhand, both A/GV17 and A/Zhang/57 have a single base change corre-
sponding to a single amino acid substitution at residue 207. In the case ofA/GV17,
the asparagine at207was changedto alysine, whilein theA/Zhang/57, the asparagine
at 207 was replaced by an aspartic acid. Furthermore, the A/AA/57 (and two other
strains, A/Eng/1/61 andA/Okuda/57, withasimilarpattern ofrecognition; not shown)
also varied from the A/JAP/57 sequence at one residue, in this case at position 215
where theglycinehasbeen replaced bya serine. Asnoted above(Table I), the A/AA/57
HAis not recognized by clones 40-1 and 40-2. Itdoes, however, retain theasparagine
at position 207 and is recognized by clones 11-1, 14-1, 14-2, 17-2, and 17-4.
This structural informationsuggested thatthe asparagine atposition 207 was crit-
ical for recognition by oneCTL subset (11-1, 14-1, 14-2, 17-2, 17-4), whilethe glycine
at position 215 was essential for the other CTL subset (40-1, 40-2). To directly test
thispossibility, syntheticpeptides correspondingtoA/JAP/57 HA 202-221 were syn-
thesized thatcontained, (a) the asparagine-lysineorasparagine-aspartic acid sub-
stitutions at position 207 (designated HA 202-221,K207, and HA 202-221,D207,
respectively); (b) the glycine-serine substitution at position 215 (202-221,S215); or
(c) the 202-221 site with substitutions at both 207 and 215 (202-221,K207,S215).
AsTable IIIshows, while theprototypeA/JAP/57 HA 202-221 peptideis efficiently
recognized by each of the CTL clones, the asparagine-lysine substitution at 207
abolishes recognitionbyclones 11-1, 14-1, 14-2, 17-2, and 17-4, but notby CTL clone
40-2. Conversely, the glycine-serine change at position 215 abolishes recognition
ofthe peptide by 40-2 but not by the other clones. Importantly, none of the clones
recognize the 202-221,K207,S215 peptide, further implicating the two residues at
positions 207 and 215 ascritical forCTL recognition. Alsonoteworthywasthefinding
FIGURE 1.
￿
Amino acid sequence of
the HA 202-221 region ofearly H2N2
strains. Viral RNA of the various
strains was isolated and sequenced as
described in Materials and Methods.
The deduced amino acid sequence is
shown. Dashes indicate identity with
residue in A/JAP/57 HA 202-221.
202 205 210 215 221
A/JAP/305/57 RTLYQNVGTYVSVGTST LN K
A/Shanghai/1/51 --------------------
A/Guiyang/1/57 --------------------
A/Singapore/202/57 --------------------
A/G1117 -----K--------------
A/Zhang/4/57 -----0--------------
A/AA/23/57 -------------S------1362
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TABLE III
Recognition of HA 202-221 Region Peptides
P815 mastocytoma cells were labeled with 51Cr and assayed for lysis by the
CTL clones listed in the presence of the synthetic peptides at the indicated
concentration. Assay time was 6 h.
l Indicates sequence of the synthetic peptide used to treat the target cells. The
designations 207K, 2071), and 215S indicate synthetic HA 202-221 peptides
with substitutions of lysine or aspartic acid at position 207 or serine at posi-
tion 215 . The type A influenza strain with the corresponding amino acid sub-
stitution in the HA is noted in parentheses.
§ As in Table I.
II As in Table I.
that substitution of theasparagine at position 207to aspartic acid differentially affected
CTL recognition. For one clone, 14-1, the asparagine-aspartic acid change at posi-
tion 207 markedly diminishes recognition of the peptide. For other clones, the pri-
mary effect of this substitution is a shift in the peptide dose dependence of target
cell recognition. In this regard, it should be noted that the peptide dose dependence
oftarget cell sensitization for clones 17-2 and 17-4 is less dramatically inhibited than
that of clones 11-1 and 14-1.
Two Distinct Epitopes Map within HA 202-221.
￿
The data in Table III clearly show
that within the 202-221 site, residue 207 is critical forclones of which 11-1 is repre-
sentative, while clones of which 40-2 is representative are unaffected by changes at
position 207 but aresensitiveto amino acid substitutions at residue215. Thesefindings
are compatible with a model of a single antigenic site spanning residues 207 and
215, in which residues critical for T cell recognition by each subset of clones are
Peptide
sequencel
Peptide
concentration
Percent
40-2§ 11-1
specific 5'Cr release from
target cells'
14-1 14-2 17-2 17-4
fcglmi
Medium - 711 6 12 6 5 8
202-221 10 83 79 88 81 79 88
(A/JAP/57) 1 83 85 87 74 82 94
0.1 87 82 64 39 44 72
0.01 89 24 20 16 8 23
0.001 39 7 12 7 4 8
202-221,207K 10 85 8 11 5 5 10
(A/GV17) 1 83 5 11 6 5 8
0.1 85 6 12 8 6 9
0.01 70 5 14 7 5 9
202-221,215S 10 8 82 89 84 84 83
(A/AA/57) 1 9 88 89 77 83 90
0.1 10 84 68 46 52 79
0.01 11 26 22 19 11 28
202-221,2071) 10 93 48 18 54 81 87
(A/Zhang/57) 1 92 16 16 36 62 84
0.1 89 9 15 13 16 36
0.01 47 7 14 9 9 14
202-221, 10 9 17 18 14 7 18
207K,215S 1 12 9 13 9 6 11Synthetic Peptide Sequence
￿
1L-1
￿
411=2
202 205 210 215
￿
221
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FIGURE 2.
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MappingtheCTLepitopes with-
in the 202-221 region of the HA. Synthetic
peptides were synthesized and tested in stan-
dard 6-h "Cr release assays for their ability
to sensitize P815 cellsforlysisby the HA-spe-
cificclassI-restricted CTLclones. Peptide was
added at final concentrations ranging from
5 x 10-9 to 5 x 10-6 M and maintained
throughout theassay. E/Tratios were 5:1 and
1:1 . Peptides were screened fortarget cell sen-
sitizationwith 8-10 distinct classICTLclones
representative of the specificities defined by
clones 11-1 and 40-2, respectively. (+) Target
cell sensitization identical in specificity and
efficiency to the HA 202-221 synthetic pep-
tide; (-)no recognition ofthepeptide-treated
target cells by the class I CTL at concentra-
tionsup to 5 x 10-6 M; (+/-) intermediate
efficiency of target cell sensitization by the
peptide.
located at either the NH2 or COOH terminus of the determinant, while residues
essential for MHC binding are located centrally. An alternative wouldbe wheretwo
distinguishable CTL epitopes are contained within the HA 202-221 region.
To better define the boundaries of the epitope(s) mimicked by the HA 202-221
peptide, we synthesized a set of nested peptides within the HA 202-221 region
and tested theirrecognition by the CTLclones. As revealed in Fig. 2, the immuno-
dominant region defined by HA 202-221 can be subdivided into two distinguish-
able sites. CTL clones represented by clone 11-1 recognize the synthetic NH2-ter-
minal 11-mer RTLYQNVGTYVcorresponding to residues 202-212. TheCTL clones
represented by 40-2 recognize the COOH-terminal 11-mer YVSVGTSTLNK cor-
responding to residues 211-221. The NH2-terminal 202-212 site and the COOH-
terminal 211-221 site overlap at two residues Y and V at positions 211 and 212.
Discussion
In this report we have examined the fine specificity of H-2Kd-restricted murine
CTLclones with anarrow reactivity fortheHAoftheimmunizingA/JAP/57 influenza
virus and antigenically closely related HAs of influenza strains ofthe H2N2 sub-
type: Using this panel of field strains, we found that the class I CTL clones could
bedivided into two groups based on their differential recognition ofthe HAs ofthe
A/Zhang/57 and A/AA/57 viruses. Since all ofthese clones are directed to an im-
munodominant region oftheA/JAP/57 HA correspondingtoHA 202-221, theCTL
clones appeared to define twodistinct epitopes within the HA 202-221 site. Support
for this concept came from sequencingofthe HA genes offield strains in the region
correspondingtoA/JAP/57 HA 202-221. This analysisrevealed that asingle amino
acid substitution at position 207 in the A/Zhang/57 HA and at position 215 in the
A/AA/57 resulted in the selective loss ofone or the other of these epitopes. That
R T L Y Q N V G T Y V S V G T S T L N K + +
VSVGTSTLNK - -
Y V S V G T S T L N K - +
TYVSVGTSTLNK - +
N V G T Y V S V G T S T L N K - +
0NVGTYVSVGTSTLNK - +
Y0NVGTYVSVGTSTLNK - +
L Y Q N V G T Y V S V G T S T L N K + +
TLY0NVGTYVSVGTSTLNK + +
TLYQNVGTYVSVGTSTL + +
T L Y Q N V G T Y V S V G T S T + -
TLYQNVGTYVSVGTS + -
T L Y Q N V G T Y V S V G T + -
T L Y Q N V G T Y V S + -
R T L Y Q N V G T Y V + -
Q R T L Y Q N V G T Y +/- -1364
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the HA 202-221 site contains two distinguishable epitopes was directly supported
by studies on class I CTL recognition oftarget cells treatedwith a nested set ofsyn-
thetic peptides spanning portions of the HA 202-221 site.
Of interest in these analyses was the finding that an mAb-selected variant virus,
A/GV17, had lost one of the two epitopes contained within the HA 202-221 site.
Sequencing of the A/GV17 HA gene in this region revealed a single base change
resulting in an asparagine-lysine substitution at position 207. The importance of
the asparagine at position 207 for CTL clone 11-1 and related clones was confirmed
by studies with a synthetic HA 202-221 peptide containing the asparagine-lysine
substitution at position 207. The class I CTL clones show comparable reactivity
on target cells treated with this peptide or targets infected with the A/GV17 variant
virus strain. It is noteworthy that on the three-dimensional crystal structure of the
H3 subtype hemagglutinin (6), residues 202-221 ofthe A/JAP/57 HA correspond
to residues 192-211 of the H3 HA. This sequence is located on the outer surface
ofthe HA globular head beginning within an a helix structure preceding /3 strand
number 4 (H3 residues 200-205) and ending in (3 strand number 5 (H3 residues
210-213). It is also in close proximity to the sialic acid receptor binding site and
encompasses portions of two of the major neutralizing antibody sites on the HA,
i.e., sites B and D (4). The asparagine at position 207 in the A/JAP/57 HA, which
is critical for recognition by one subset ofclass I CTL clones (represented by 11-1),
appears exposed onthe surface ofthe HAwithin antigenic site B. Likewise, the gly-
cine at position 215, which is essential for recognition by the other subset ofCTL
clones (represented by 40-2), is in antigenic site D in the interface region formed
by HA trimerization.
These data on the recognition offield strains and particularly A/GV17 by these
CTL indicate that amino acids implicated in antigen recognition by the T cells are
also critical for antibody recognition. The antigenic sites recognized by class I T
lymphocytesand neutralizing antibodies, therefore, candirectlyoverlap, ashas been
noted for influenza HA epitopes (9, 34) recognized by class II T lymphocytes. T
lymphocytes and B lymphocytes, however, can recognize unrelated sites on a given
protein antigen. This has been well documented for sites recognized by class 11 T
lymphocytes directed toboth soluble globular proteins (35-38) and membrane pro-
teins like the influenza HA (9). The fact that the transmembrane domain of the
HA is recognized by HA-specific class I-restricted CTL (26) reinforces this view,
since the transmembrane domain ofthe HA is embedded in the lipid bilayer ofthe
virion or infected cell and is probably not accessible to antibody.
The two Kd-restricted epitopes in HA 202-221 can be defined by peptides 202-
212 (RTLYQNVGTYV) and 211-221 (YVSVGTSTLNK), respectively. These two
regions overlap in two residues, i.e., the tyrosine at position 211 and the valine at
position 212. Both residues are required for epitope recognition by either subset of
clones. These two epitopes exhibit considerable sequence homology and each con-
tains a five-residue motifcharacteristic ofT cell sites (39). Each epitope also shows
modest homology with other antigenic sites recognized in association with H-2Kd
(39). These results raise the possibility that a class I T cell site for the H-2d haplo-
type has been tandemly duplicated within the A/JAP/57 HA. This may explain the
potency ofthe A/JAP/57 HA over HAs ofother subtypes in stimulating class I T
lymphocyte responses (T. J. Braciale, unpublished observations).SWEETSER ET AL.
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We foundthat the asparagine-"lysine change at residue 207 abolishes CTL recog-
nition of target cells treated with the synthetic peptide containing this substitution
(Table III) and of infected target cells expressing the A/GV17 HA containing this
substitution (Table I). On theotherhand, while the asparagine-aspartic acid change
at position 207 didmarkedly reduce recognition oftarget cellsinfected with A/Zhang/
57 virus, the synthetic 202-221 peptide with the aspartic acid substitution at posi-
tion 207 is recognized by most ofthe CTL clones (Table III). However, this substitu-
tion does lead to a decrease in the efficiency of peptide recognition with a shift in
the dose response curve for the 11-1 subset of clones. This finding suggests that the
asparagine-asparticacid change at position 207 (unlike the asparagine-lysinechange)
leads to an antigenic moiety that binds MHC and interacts with the TCR on the
clones to a sufficient extent to permit target cell recognition, albeit with aloweroverall
efficiency. The failure of most clones to recognize A/Zhang/57-infected cells may
well mean that the concentration of processed HA antigen is normally low in an
infected cell andthat the processed HA antigen moiety containing the asparagine->
aspartic acid substitution does not form a sufficient number of complexes to be
efficiently recognized. In this connection it is noteworthy that clones 17-2 and 17-4
do show low but significant lysis of A/Zhang/57-infected cells (Table I) . These two
clones are also the most efficient at recognizing the 202-221 peptide with the
asparagine-aspartic acid change at position 207. Thus, theirantigen receptors may
recognize with sufficient avidity this peptide/MHC complex.
At present we do not know whether the mutations at position 207 and 215 affect
peptide binding to MHC and/or the efficiency TCR interaction with this complex.
The finding that two different substitutions at 207 differentially affect recognition
of this epitope by CTL would suggest that residue 207 may be critical for TCR rec-
ognition rather than interaction of the peptide with MHC. Such fine specificity of
recognition by class I CTL has been previously reported (40). Furthermore, if HA
202-221 contains a tandem duplication of a Kd binding site, then loss of MHC
binding capacity by a mutation within one site, e.g., position 207 in the 202-212
site, should be compensated by peptide bindingthroughresidues in the other, 211-221,
site. As noted in Table III, the HA 202-221,K207 peptide efficiently binds to Kd,
as evidenced by the efficientrecognitionof this peptide by clone 40-2, yet, no recog-
nition of this peptide by clone 11-1, and related clones, is evident. Experiments are
now in progress to directly assess the contribution of individual residues to MHC
binding and antigen receptor recognition.
In conclusion, we have analyzed asite on the influenza HA that contains residues
recognized by both class I-restricted CTL and antibody. The site has the unusual
property of encompassing two distinct epitopes that may represent a tandem dupli-
cation of a T cell recognition site. It is notknown whether both epitopes are present
in the endogenously processed form ofthe antigen generatedin virally infected targets
or if these epitopes are generated by separate proteolytic cleavage events. Dissection
of this site and the HA antigenic moiety generated during viral infection should
provide further insight into the mechanism of antigen processing.
Summary
The influenza hemagglutinin is a critical regulator of disease expression during
influenzavirus infection and serves as a major target for the host immune response1366
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to this pathogen. In this report, we have analyzed an immunodominant site on the
hemagglutinin (residues 202-221) recognized by murine class I MHC-restricted T
lymphocytes. This analysis has revealed evidence for the duplication of a T cell rec-
ognition site within the region 202-221. We have also identified critical amino acids
necessary for class I-restricted T cell recognition within these two epitopes. In addi-
tion, we provide evidence that a site on the influenza hemagglutinin recognized by
neutralizing antibody directly overlaps with an epitope recognized by class I MHC-re-
stricted CTL.
We thank Dr. R. Webster for providing us with a large panel ofmAb-selected virus variants;
Dr. G. Air and M. Els for advice in sequencing viral RNA; Michelle Winkler Luche, Belinda
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making available unpublished data; and Mrs. Jerri Smith for expert, patient, and dedicated
secretarial support in the preparation of this work. Particular thanks toJohn Gorka and Dr.
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